Thermal injury from biliary sphincterotomy is thought to play a role in at least a proportion of post-ERCP pancreatitis (PEP) cases. Thus, the present study
PEP
PEP
True Rate of Post-ERCP Pancreatitis: Do Randomized Trials Provide the Answer?
Pancreatitis after ERCP is one of the most common and morbid adverse events following any gastrointestinal endoscopy procedure. It is imperative that the consent process
On Balance, Benefit of Sphincterotomy for Biliary Stenting Appears to Outweigh the Risk
Limited reports have suggested that endoscopic biliary sphincterotomy (ES) at the time of transpapillary biliary stent placement may reduce the risk of post-ERCP pancreatitis (PEP).
Further Evidence Supporting Early, Primary Use of Precut Sphincterotomy for Duct Access
Deep access to the bile duct or the pancreatic duct is required in order to complete all subsequent therapeutic ERCP maneuvers. Precut sphincterotomy (PCS) refers
Prophylaxis for Post-ERCP Pancreatitis Appears Underutilized
Post-ERCP pancreatitis (PEP) remains an important adverse event. Indomethacin suppositories and pancreatic duct (PD) stents have both been demonstrated to reduce PEP in patients at
Zweifel an der Wirksamkeit von NSAR gegen die Post-ERCP-Pankreatitis ?
Der Einsatz von nicht-steroidalen Antirheumatika (NSAR) wie zum Beispiel Indometacin oder Diclofenac zur Prävention der post-ERCP-Pankreatitis (PEP) wurde durch zahlreiche Studien weltweit belegt obwohl nicht
